Skip to main content
Diamines & Chemicals Ltd. logo

Diamines & Chemicals Ltd. — Investor Relations & Filings

Ticker · DIAMINESQ ISIN · INE591D01014 LEI · 335800AQNIZET87LXI95 BSE.NS Manufacturing
Open in API
Filings indexed 873 across all filing types
Latest filing 2023-02-22 Regulatory Filings
Country IN India
Listing BSE.NS DIAMINESQ

About Diamines & Chemicals Ltd.

https://dacl.co.in/

Diamines & Chemicals Ltd. specializes in the production of ethylene amines and related chemical intermediates. The company’s core product portfolio includes Ethylenediamine (EDA), Diethylenetriamine (DETA), Triethylenetetramine (TETA), Tetraethylenepentamine (TEPA), and Piperazine. These specialty chemicals are utilized across diverse sectors, including pharmaceuticals, agrochemicals, polyamide resins, and water treatment. The firm operates integrated manufacturing facilities designed for the synthesis of high-purity organic compounds. By leveraging advanced chemical processes, it provides essential raw materials for applications in oilfield chemicals, textile auxiliaries, and paper chemicals. The organization maintains a focus on technical excellence and process innovation to meet the stringent requirements of global supply chains.

Recent filings

Filing Released Lang Actions
We submit herewith information regarding loss/misplaced/non-receipt of Share Certificate received from our Registrar and Transfer Agent of the Company.
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the loss/misplacement/non-receipt of share certificates and the issuance of duplicate share certificates. It is a regulatory compliance communication to the stock exchange and does not contain financial statements, management discussion, or report data. It is not an annual report, earnings release, or any financial report. It is also not a voting result, board change, or capital change announcement. The document is a regulatory filing notifying the exchange of a corporate action related to share certificates as required by SEBI regulations. Therefore, it fits best under Regulatory Filings (RNS). The document length is short and it is a formal notification rather than a report or announcement of a report publication.
2023-02-22 English
We submit herewith information regarding loss/misplaced/non-receipt of Share Certificate received from our Registrar and Transfer Agent of the Company.
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the loss/misplacement/non-receipt of share certificates and the issuance of duplicate share certificates. It is a regulatory announcement related to share certificate status and does not contain financial data, management discussion, or report content. It is not a report or financial statement but a regulatory filing notifying the stock exchange of a corporate action related to share certificates. Therefore, it fits best under Regulatory Filings (RNS). The document length is short and it is an official notification rather than a report or announcement of a report publication.
2023-02-21 English
We submit herewith information regarding loss/misplaced/non-receipt of Share Certificate received from our Registrar and Transfer Agent of the Company.
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the loss/misplaced/non-receipt of share certificates and the issuance of duplicate share certificates. It is a regulatory announcement related to share certificate status and compliance with listing obligations. The document is short (1714 characters) and does not contain financial data, management discussion, or detailed report content. It is not a financial report, earnings release, or management report. It is a regulatory filing notifying the stock exchange and shareholders about a corporate action related to share certificates. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-02-17 English
We submit herewith information regarding loss/misplaced/non-receipt of Share Certificate received from our Registrar and Transfer Agent of the Company.
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the loss/misplacement/non-receipt of share certificates and the issuance of duplicate share certificates. It is a regulatory compliance announcement related to share certificate status and does not contain financial statements, management discussion, or other report content. The document is short (2132 characters) and serves as a formal notification to the stock exchange. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-02-16 English
With reference to intimation made on August 10, 2022, this is to inform that the DACL Fine Chem Limited, WOS of the Company in its board meeting held on February 06, 2023 has allotted 1% ....
Capital/Financing Update Classification · 95% confidence The document is a notification about the allotment of preference shares by a wholly owned subsidiary against the transfer of an industrial plot. It references a board meeting decision and details the share allotment but does not contain financial statements or detailed financial analysis. The document length is short (1617 characters) and is an announcement of a capital transaction rather than a full report. Therefore, it fits the category of Capital/Financing Update (CAP).
2023-02-07 English
We submit herewith Standalone and Consolidated Unaudited Financial Results along with Limited Review Report for the quarter and nine months ended December 31, 2022.
Interim / Quarterly Report Classification · 100% confidence The document is dated February 7, 2023, and reports the outcome of a Board Meeting held on the same date. It includes approval of standalone and consolidated unaudited financial results for the quarter and nine months ended December 31, 2022, along with a Limited Review Report by the auditors. The document contains detailed financial data for the quarter and nine months, including revenue, expenses, profit before tax, tax expenses, and earnings per share. The presence of unaudited financial results for a quarter and nine months period, along with a limited review report, indicates this is a quarterly/interim financial report. The document is comprehensive and contains substantive financial data and analysis, not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2023-02-07 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.